tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Les Sulewski, 38 are a BUY (88.37%), 5 are a HOLD (11.63%).
Analyst Les Sulewski, currently employed at TRUIST, carries an average stock price target met ratio of 43.58% that have a potential upside of 22.68% achieved within 130 days. Previously, Les Sulewski worked at OPPENHEIMER.
Les Sulewski’s has documented 86 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PCRX, Pacira Pharmaceuticals at 07-Oct-2026.
Analyst best performing recommendations are on PCRX (PACIRA PHARMACEUTICALS).
The best stock recommendation documented was for PCRX (PACIRA PHARMACEUTICALS) at 10/7/2026. The price target of $31 was fulfilled within 1 day with a profit of $5.8 (23.02%) receiving and performance score of 230.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2025
$24
$3.52 (17.19%)
$22
Buy Since 02-May-2024
$27
$6.52 (31.84%)
$17
1 months ago
(22-Sep-2026)
8/9 (88.89%)
$7.67 (39.68%)
158
Buy Since 19-May-2026
$20
$-0.48 (-2.34%)
$16
1 months 6 days ago
(16-Sep-2026)
2/2 (100%)
$1.72 (9.41%)
13
Buy Since 16-Apr-2026
$25
$4.52 (22.07%)
$23
2 months 20 days ago
(02-Aug-2026)
1/3 (33.33%)
$6.15 (32.63%)
103
Buy Since 07-Aug-2023
$13
$-4.23 (-24.55%)
$11
11 months 22 days ago
(31-Oct-2025)
8/8 (100%)
$2.18 (20.15%)
413
Which stock is Les Sulewski most bullish on?
Which stock is Les Sulewski most reserved on?
What Year was the first public recommendation made by Les Sulewski?
